Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control study.

Autor: Calvo DM; Autonomous University of Barcelona (UAB), Barcelona, Spain., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Leache L; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Celaya MC; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Gutiérrez-Valencia M; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Alonso A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Erviti J; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Alzueta N; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Echeverría A; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Garjón J; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Fontela C; Pharmacy Service, Donostia University Hospital, OSI Donostialdea, Osakidetza, San Sebastián, Spain., Sanz L; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Pamplona, Spain., Acín MT; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Fernández ML; Nephrology Service, Navarre University Hospital, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Gómez N; Nephrology Service, Navarre University Hospital, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Aug; Vol. 32 (8), pp. 898-909. Date of Electronic Publication: 2023 Apr 05.

Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis.

Autor: Alzueta N; Hospital Reina Sofía, Navarre Health Service, 31500 Tudela, Spain.; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain., Echeverría A; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Subdirectorate of Pharmacy, Navarre Health Service, 31002 Pamplona, Spain., García P; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Subdirectorate of Pharmacy, Navarre Health Service, 31002 Pamplona, Spain., Sanz L; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Subdirectorate of Pharmacy, Navarre Health Service, 31002 Pamplona, Spain., Gil-Setas A; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Clinical Microbiology Department, Hospital Universitario de Navarra, Navarre Health Service, 31008 Pamplona, Spain., Beristain X; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Clinical Microbiology Department, Hospital Universitario de Navarra, Navarre Health Service, 31008 Pamplona, Spain., Aldaz P; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; San Juan Primary Care Center, Navarre Health Service, 31011 Pamplona, Spain., Garjón J; IdiSNA, Health Research Institute of Navarre, 31008 Pamplona, Spain.; Subdirectorate of Pharmacy, Navarre Health Service, 31002 Pamplona, Spain.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Feb 03; Vol. 12 (2). Date of Electronic Publication: 2023 Feb 03.

A strategy for urinary incontinence treatments deprescription.

Autor: Alzueta N; Medicines Advice and Information Service. Navarre Health Service, Spain. Electronic address: nalzueti@navarra.es., Fontela C; Medicines Advice and Information Service. Navarre Health Service, Spain., Echeverría A; Medicines Advice and Information Service. Navarre Health Service, Spain.

Publikováno v: Medicina clinica [Med Clin (Barc)] 2021 May 07; Vol. 156 (9), pp. 465-466. Date of Electronic Publication: 2020 Jul 04.

Bullous pemphigoid induced by ustekinumab: a case report.

Autor: Marin M; Pharmacy, Hospital Reina Sofia, Tudela, Spain mmarinma@gmail.com., Alzueta N; Pharmacy, Hospital Reina Sofia, Tudela, Spain., Castresana M; Pharmacy, Hospital Reina Sofia, Tudela, Spain., Gascón A; Pharmacy, Hospital Reina Sofia, Tudela, Spain., Pío M; Pharmacy, Hospital Reina Sofia, Tudela, Spain.

Publikováno v: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2021 Jan; Vol. 28 (1), pp. 47-49. Date of Electronic Publication: 2019 May 30.

Alcohol intake reduction for controlling hypertension.

Autor: Acin MT; Drug Prescribing Service, Navarre Health Service, Pamplona, Spain., Rueda JR; Department of Preventive Medicine and Public Health, University of the Basque Country, Leioa, Spain., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain., Parent Mathias V; Hospital Regional Malaga, Sistema Andaluz de Salud, Malaga, Spain., Alzueta N; Drug Prescribing Service, Navarre Health Service, Pamplona, Spain., Solà I; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain., Garjón J; Medicines Advice and Information Service, Navarre Health Service, Pamplona, Spain., Erviti J; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Sep 21; Vol. 9. Cochrane AN: CD010022. Date of Electronic Publication: 2020 Sep 21.